Fingerprint
Dive into the research topics of 'The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
Sofia von Palffy, Hanna Thorsson, Pablo Peña-Martínez, Noelia Puente-Moncada, Carl Sandén, Anna M Blom, Rasmus Henningsson, Gunnar Juliusson, Ben King, Niklas Landberg, Vladimir Lj Lazarevic, Christina Orsmark-Pietras, Marianne Rissler, Vendela Rissler, Helena Ågerstam, Marcus Järås, Henrik Lilljebjörn, Thoas Fioretos
- LUCC: Lund University Cancer Centre
- Translational Genomic and Functional Studies of Leukemia
- Division of Clinical Genetics
- Targeted therapies in leukemia
- EXODIAB: Excellence of Diabetes Research in Sweden
- Department of Translational Medicine
- Protein Chemistry, Malmö
- Leukemia, Genetics, Epidemiology
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy
Research output: Contribution to journal › Article › peer-review